| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.06 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |